What this case does and does not tell you

Supported by this case: the corrected calcium formula is an estimate, not a measurement, and it is known to perform poorly in hypoalbuminemia; the elevated PTH is a genuine discordant signal against a fully-explained low calcium; low 25(OH)D and low albumin together make reduced intestinal calcium absorption a reasonable working explanation; and eGFR of 78 argues against a CKD-driven pattern here.

Not supported by this case: a diagnosis of primary hyperparathyroidism, hypoparathyroidism, or CKD-mineral and bone disorder. None of those labels fit the pattern of results seen, and none should be assigned from one panel without the direct ionized calcium measurement and, if indicated, follow-up testing.

What depends on local policy: the exact reference intervals printed on any report for calcium, phosphate, magnesium, PTH, and vitamin D markers; whether the laboratory reports a corrected calcium value at all and what wording accompanies it; which PTH assay generation is in current use; the numeric 25(OH)D flag used locally, because no single universal target applies; the specimen device, fill volume, and turnaround time validated for ionized calcium; and the laboratory's own critical-value policy for these analytes, since CLIA (42 CFR 493.1291) requires a documented policy but sets no fixed number.

Method and scope caveats: PTH interpretation here uses one method (Roche Elecsys ECLIA) and describes ionized calcium by ion-selective electrode and total calcium by spectrophotometric colorimetric chemistry as common method families; exact platform, reagent lot, and calibration must be confirmed against the local manufacturer's instructions for use. Patient-specific supplementation and treatment decisions are not covered here.

A pattern across calcium, PTH, phosphate, magnesium, and vitamin D is more trustworthy than any single flagged value, and the specimen and method behind each number are part of the interpretation, not background detail.